Emergent immunoregulatory properties of combined glucocorticoid and anti-glucocorticoid steroids in a model of tuberculosis

QJM: An International Journal of Medicine

Volumn 91, Issue 11, 1998, Pages 755-766

  Hernandez Pando, R ^a   De La Luz Streber, M ^a   Orozco, H ^a   Arriaga, K ^a   Pavon, L ^a   Marti, O ^b   Lightman, S L ^b   Rook, G A W ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA ANDROSTANEDIOL; CORTICOSTERONE; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 1ALPHA; PRASTERONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL HYPERPLASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FATALITY; HELPER CELL; IMMUNOREGULATION; LUNG TUBERCULOSIS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031789957     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.11.755     Document Type: Article

References (56)

1. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 1995; 2:561-72.
2. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
3. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186:39-45.
4. Hernandez-Pando R, Pavón L, Arriaga K, Orozco H, Madrid-Marina V, Rook GAW. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte. Infect Immun 1997; 65:3317-27.
5. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7.
6. Hernandez-Pando R, Orozco H, Sampieri A, Pavón L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996; 89:26-33.
7. Hernandez-Pando R, Orozco H, Honour JP, Silva J, Leyva R, Rook GAW. Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? FEMS Immunol Med Microbiol 1995; 12:63-72.
8. Rook GAW, Hernandez-Pando R. The pathogenesis of tuberculosis. Ann Rev Microbiol 1996; 50:259-84.
9. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156:2406-12.
10. Brinkmann V, Kristofic C. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO-and CD45RO+ subsets. I Immunol 1995; 155:3322-8.
11. Fischer A, Konig W. Influence of cytokines and cellular interactions on the glucocorticoid-induced Ig (E, G, A, M) synthesis of peripheral blood mononuclear cells. Immunology 1991; 74:228-33.
12. Wu CY, Sarfati M, Heusser C, Fournier S, Rubio-Trujillo M, Peleman R, Delespesse G. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J Clin Invest 1991; 87:870-7.
13. Guida L, O'Hehir RE, Hawrylowicz CM. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood 1994; 84:2733-40.
14. Padgett DA, Sheridan JF, Loria R. Steroid hormone regulation of a polyclonal Th2 immune response. Ann NY Acad Sci 1995; 774:323-5.
15. Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 1992; 55:600-8.
16. MacPhee IAM, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989; 169:431-45.
17. McCune RM, Feldmann FM, McDermott W. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med 1966; 123:469-86.
18. McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med 1966; 123:445-68.
19. Brown DH, Sheridan J, Pearl D, Zwilling BS. Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: Differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice. Infect Immun 1993; 61:4793-800.
20. Blauer KL, Poth M, Rogers WM, Bernton EW. Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 1991; 129(6):3174-9.
21. Wright BE, Porter JR, Browne ES, Svec F. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obesity 1992; 16:579-83.
22. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W. Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Am J Med Sci 1994; 131:99-104.
23. Suzuki T, Suzuki N, Daynes RA, Engleman EG. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 1991; 61:202-11.
24. Daynes RA, Araneo BA, Hennebold J, Enioutina J, Mu HH. Steroids as regulators of the mammalian immune response. J Invest Dermatol 1995; 105:14S-19S.
25. Tabata N, Tagami H, Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res 1997; 289:410-14.
26. Hernandez-Pando R, de la Luz Streber M, Orozco H, Arriaga K, Pavon L, Al-Nakhli SA, Rook GAW. The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in Balb/c mice. Immunology 1998; in Press.
27. Hernandez-Pando R, Rook GAW. The role of TNFα in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994; 82:591-5.
28. Morfin R, Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Mol Biol 1994; 50:91-100.
29. Garg M, Bondada S. Reversal of age-associated decline in immune response to Pnu-imune vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infect Immun 1993; 61:2238-41.
30. Häusler A, Persoz C, Buser R, Mondadori C, Bhatnagar A. Adrenalectomy, corticosteroid replacement and their importance for drug-induced memory enhancement in mice. J Steroid Biochem Mol Biol 1992; 41:785-9.
31. Shanks N, Moore PM, Perks P, Lightman SL. Endocrine correlates of murine systemic lupus erythematosus in the MRL lpr/lpr model. Ann NY Acad Sci 1997; 823:252-8.
32. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56:731-40.
33. Harbuz MS, Jessop DS, Chowdrey HS, Blackwell JM, Larsen PJ, Lightman SL. Evidence for altered control of hypothalamic CRF in immune-mediated diseases. Ann NY Acad Sci 1995; 771:449-58.
34. Browne ES, Wright BE, Porter JR, Svec F. Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 1992; 303:366-71.
35. Giroix MH, Malaisse-Lagae F, Portha B, Sener A, Malaisse WJ. Effects of dehydroepiandrosterone in rats injected with streptozotocin during the neonatal period. Biochem Mol Med 1997; 61:72-81.
36. Fleshner M, Pugh CR, Tremblay D, Rudy JW. DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis. Behav Neurosci 1997; 111:512-17.
37. Crossin KL, Tai MH, Krushel LA, Mauro VP, Edelman GM. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci USA 1997; 94:2687-92.
38. Loria RM, Inge TI, Cook SS, Szakal AK, Regelsen W. Protection against acute lethal virus infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol 1988; 26:301-14.
39. Gennari R, Alexander JW. Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis [see comments]. Crit Care Med 1997; 25:1207-14.
40. Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990; 171:979-96.
41. Araghi-Niknam M, Liang B, Zhang Z, Ardestani SK, Watson RR. Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by dehydroepiandrosterone sulphate (DHEAS). Immunology 1997; 90:344-9.
42. Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci 1997; 52:M1-M7.
43. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82:2396-402.
44. Padgett DA, Loria RM. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J Immunol 1994; 153:1544-52.
45. Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, Belanger A. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997; 62:148-58.
46. Andersson S. 17β-hydroxysteroid dehydrogenase: isozymes and mutations. J Endocrinol 1995; 146:197-200.
47. Milewich L, Garcia RL, Gerrity LW. 17 beta-Hydroxysteroid oxidoreductase: a ubiquitous enzyme. Interconversion of estrone and estradiol-17 beta in BALB/c mouse tissues. Metabolism 1985; 34:938-44.
48. Robel P, Baulieu EE. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann NY Acad Sci 1995; 774:82-110.
49. Rook GAW, Hernandez-Pando R, Baker R, Orozco H, Arriaga K, Pavon L, Streber M. Human and murine tuberculosis as models for immuno-endocrine interactions. In: Rook GAW, Lightman S, eds. Steroid hormones and the T cell cytokine profile. London, Springer, 1997:193-220.
50. Hennebold JD, Daynes RA. Microenvironmental control of glucocorticoid functions in immune regulation. In: Rook GAW, Lightman SL, eds. Steroid hormones and the T-cell profile. London, Springer, 1997:101-33.
51. Suitters AJ, Shaw S, Wales M, Porter J, Leonard J, Woodger R, Brand H, Bodmer M, Foulkes R. Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase. Immunology 1997; 91:314-21.
52. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL, Daynes RA. The presence of a dehydroepiandrosterone-specific receptor-binding complex in murine T cells. J Steroid Biochem Mol Biol 1992; 42:293-304.
53. Rook GAW, Honour J, Kon OM, Wilkinson RJ, Davidson R, Shaw RJ. Urinary steroid metabolites in tuberculosis: a new clue to pathogenesis. Q J Med 1996; 89:333-41.
54. Parker CR, Schuster MW. Effects of syphilis infection on adrenocortical function in men. Proc Soc Exp Biol Med 1991; 197:165-7.
55. Wisniewski TL, Hilton CW, Morse EV, Svec F. The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 1993; 305:79-83.
56. Donald PR, Beyers N, Rook GAW. Adolescent tuberculosis. S African Med J 1996; 86:231-3.